Acella's $46.5M Drug Recall Settlement Gets Initial Signoff

By Peter McGuire · February 7, 2024, 6:41 PM EST

A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication...

To view the full article, register now.